关键词: artificial intelligence cardiovascular coronary artery disease healthcare mhealth public health review

来  源:   DOI:10.7759/cureus.62157   PDF(Pubmed)

Abstract:
Mobile health (mHealth) interventions have emerged as a promising approach for cardiovascular disease (CVD) prevention and management. The proliferation of smartphones and wearable devices enables convenient access to health monitoring tools, educational resources, and communication with healthcare providers. mHealth interventions encompass mobile apps, wearables, and telehealth services that empower users to monitor vital signs, adhere to medication, and adopt healthier lifestyles. Their effectiveness hinges on user engagement, leveraging behavioral science principles and gamification strategies. While mHealth offers advantages such as personalized support and increased reach, it faces challenges pertaining to data privacy, security concerns, and resistance from healthcare providers. Robust encryption and adherence to regulations like the Health Insurance Portability and Accountability Act (HIPAA) are crucial for safeguarding sensitive health data. Integrating mHealth into clinical workflows can enhance healthcare delivery, but organizational adjustments are necessary. The future of mHealth is closely intertwined with artificial intelligence (AI), enabling remote monitoring, predictive algorithms, and data-driven insights. Tech giants are incorporating advanced health-tracking capabilities into their devices, paving the way for personalized wellness approaches. However, mHealth grapples with ethical dilemmas surrounding data ownership, privacy breaches, and inadvertent data capture. Despite its potential, mHealth necessitates a concerted effort to overcome obstacles and ensure ethical, secure, and practical implementation. Addressing technical challenges, fostering standardization, and promoting equitable access are pivotal for unlocking the transformative impact of mHealth on cardiovascular health and reducing the global burden of CVD.
摘要:
移动健康(mHealth)干预措施已成为心血管疾病(CVD)预防和管理的一种有前途的方法。智能手机和可穿戴设备的激增使人们能够方便地访问健康监测工具,教育资源,以及与医疗保健提供者的沟通。移动健康干预措施包括移动应用程序,可穿戴设备,和远程医疗服务,使用户能够监测生命体征,坚持用药,采取更健康的生活方式。它们的有效性取决于用户的参与度,利用行为科学原理和游戏化策略。虽然mHealth提供了个性化支持和扩大覆盖范围等优势,它面临着与数据隐私有关的挑战,安全问题,以及医疗保健提供者的抵制。强大的加密和遵守健康保险流通和责任法案(HIPAA)等法规对于保护敏感的健康数据至关重要。将mHealth集成到临床工作流程中可以增强医疗保健服务,但是组织调整是必要的。mHealth的未来与人工智能(AI)紧密交织在一起,启用远程监控,预测算法,和数据驱动的见解。科技巨头正在将先进的健康跟踪功能整合到他们的设备中,为个性化健康方法铺平道路。然而,mHealth努力解决围绕数据所有权的道德困境,侵犯隐私,和无意的数据捕获。尽管有潜力,mHealth需要共同努力克服障碍,确保道德,安全,和实际实施。应对技术挑战,促进标准化,促进公平获取对于释放mHealth对心血管健康的变革性影响和减轻心血管疾病的全球负担至关重要。
公众号